文献速递消化内镜消化道肿瘤与早癌

内镜细胞镜鉴别结直肠低级别腺瘤:支持「切除并丢弃」策略的新可能

Endocytoscopy for the differential diagnosis of colorectal low-grade adenoma: a novel possibility for the "resect and discard" strategy.
PubMed 文献 · Gastrointest Endosc · 2019-11-28

本研究回顾性分析2005年5月至2017年7月间可被内镜细胞镜诊断的748个结直肠腺瘤病变(573例),以正常隐窝样结构(NP征)为低级别腺瘤指标,评估其诊断准确性及用于监测结肠镜间隔推荐(SCIR)时与病理诊断的一致性。结果显示NP征诊断低级别腺瘤的敏感度85.0%、特异度90.7%、准确率86.4%,SCIR一致率在美国指南下为94.4%、欧盟指南下为96.3%,提示内镜细胞镜可用于鉴别低级别腺瘤并支持「切除并丢弃」策略。

要点

  • NP征诊断低级别腺瘤敏感度85.0%、特异度90.7%、准确率86.4%。
  • 内镜细胞镜与病理诊断的SCIR一致率美国指南94.4%、欧盟指南96.3%。
  • 观察者间与观察者内一致性除一例非专家对外κ值均≥0.8。

核心结论

  • 内镜细胞镜是鉴别结直肠低级别腺瘤的有效方法,支持「切除并丢弃」策略的可行性。

研究设计与样本

  • 回顾性研究,纳入2005年5月至2017年7月可被内镜细胞镜诊断的748个结直肠腺瘤病变(573例)。
  • 以正常隐窝样结构(NP征)作为低级别腺瘤指标,主要结局为NP征诊断低级别腺瘤的准确性。
  • 评估内镜细胞镜与病理诊断对监测结肠镜间隔推荐(SCIR)的一致率,并进行验证研究。

主要发现

  • NP征诊断低级别腺瘤:敏感度85.0%,特异度90.7%,阳性预测值96.6%,阴性预测值66.1%,准确率86.4%,阳性似然比9.2(P < .001)。
  • SCIR一致率:美国指南下94.4%(95%CI 92.2%-96.1%,P < .001),欧盟指南下96.3%(95%CI 94.5%-97.7%,P < .001)。
  • 专家与非专家内镜医师的观察者间及观察者内一致率除一例非专家对外κ值均≥0.8。

临床怎么用

  • 内镜细胞镜可用于鉴别结直肠低级别腺瘤,辅助「切除并丢弃」策略的实施。
  • 依据内镜细胞镜诊断可推荐监测结肠镜间隔,与美国和欧盟指南的一致率均高。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Endocytoscopy, a next-generation endoscopic system, facilitates observation at a maximum magnification of ×520. To our knowledge, no study has reported high-precision diagnosis of colorectal low-grade adenoma, endoscopically. We aimed to reveal which endocytoscopic findings may be used as indicators of low-grade adenoma and to assess whether a "resect and discard" strategy using endocytoscopy is feasible. METHODS: Lesions diagnosable with endocytoscopy were examined retrospectively between May 2005 and July 2017. A normal pit-like structure in endocytoscopic images was considered a normal pit (NP) sign and used as an indicator of low-grade adenoma. The primary outcome was the diagnostic accuracy of the NP sign for low-grade adenoma. We evaluated agreement rates between endocytoscopic and pathologic diagnosis for surveillance colonoscopy interval recommendation (SCIR) and performed a validation study to verify the agreement rates. RESULTS: For 748 lesions in 573 cases diagnosed as colorectal adenoma using endocytoscopy, the results were as follows: sensitivity of the NP sign for low-grade adenoma, 85.0%; specificity, 90.7%; positive predictive value, 96.6%; negative predictive value, 66.1%; accuracy, 86.4%; and positive likelihood ratio, 9.2 (P < .001). The agreement rate between endocytoscopic and pathologic diagnosis for SCIR was 94.4% (95% confidence interval [CI], 92.2%-96.1%; P < .001) under United States guidelines and 96.3% (95% CI, 94.5%-97.7%; P < .001) under European Union guidelines. All inter- and intraobserver agreement rates for expert and nonexpert endoscopists had κ values ≥0.8 except one nonexpert pair. CONCLUSIONS: Endocytoscopy is an effective modality in determining the differential diagnosis of colorectal low-grade adenoma. (University Hospital Medical Information Network Clinical Trials database registration number: UMIN000018623.).

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. Kudo T, Suzuki K, Mori Y, et al. Endocytoscopy for the differential diagnosis of colorectal low-grade adenoma: a novel possibility for the "resect and discard" strategy. Gastrointest Endosc. 2019. PMID: 31785276. doi:10.1016/j.gie.2019.11.029

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。